UK consensus statement on the use of plerixafor to facilitate autologous peripheral blood stem cell collection to support high‐dose chemoradiotherapy for patients with malignancy

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1101|33|1|46-59

ISSN： 0733-2459

Source： JOURNAL OF CLINICAL APHERESIS, Vol.33, Iss.1, 2018-02, pp. : 46-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Consolidation High-Dose Chemotherapy with Ifosfamide, Carboplatin and Etoposide (HD-ICE) Followed by Autologous Peripheral Blood Stem Cell Rescue in Chemosensitive Patients with Metastatic Soft Tissue Sarcomas

By  

Oncology, Vol. 71, Iss. 1-2, 2007-04 ,pp. : 32-39

Karger

Access to resources Recommend Favorite

Early Infectious Complications after High-Dose Therapy and Autologous Blood Stem Cell Transplantation

By  

Oncology Research and Treatment, Vol. 22, Iss. 6, 2000-01 ,pp. : 491-496

Karger

Access to resources Recommend Favorite

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

By Cheng Yee Chung   Ueno Naoto T  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite

Study of bone metabolism and angiogenesis in patients undergoing high‐dose chemotherapy/autologous hematopoietic stem cell transplantation

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 100, Iss. 2, 2018-02 ,pp. : 131-139

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicenter Randomized Phase III Study Evaluating the Role of High-Dose Chemotherapy and Peripheral Blood Progenitor Cell Support in Patients with Limited-Stage Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 21, Iss. 2, 1998-06 ,pp. : 12-14

Karger

Access to resources Recommend Favorite